Brussels - Delayed Quote EUR

Ackermans & Van Haaren NV (ACKB.BR)

228.60
+2.00
+(0.88%)
At close: May 16 at 5:35:16 PM GMT+2
Loading Chart for ACKB.BR
  • Previous Close 226.60
  • Open 227.00
  • Bid --
  • Ask --
  • Day's Range 227.00 - 228.80
  • 52 Week Range 154.20 - 229.60
  • Volume 31,141
  • Avg. Volume 31,120
  • Market Cap (intraday) 7.467B
  • Beta (5Y Monthly) 0.72
  • PE Ratio (TTM) 16.26
  • EPS (TTM) 14.06
  • Earnings Date May 22, 2025
  • Forward Dividend & Yield 3.80 (1.66%)
  • Ex-Dividend Date May 29, 2025
  • 1y Target Est 226.17

Ackermans & Van Haaren NV engages in the marine engineering and contracting, private banking, real estate and senior care, energy and resources, and growth capital businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; and specialized advisory banking services for entrepreneurs and liberal professionals, as well as financing and financial leasing services for cars, equipment, charging stations, and bicycles. The Real Estate & Senior Care segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions; and residential, retail, and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital segment provides engineering and solutions in production process automation; validation and compliance services; compact biogas installation; specialty chemicals; broadcast and media solutions for sports, entertainment, and events; online and printed news; and logistics services for rail, port and road transport, and intermodal transport, and warehousing. It also develops new vaccines, and crop and food protection products; and deals and leases commercial vehicles, as well as distributes aftermarket products. The company also develops medical devices and medicines for the treatment of cancer and genetic diseases. The company was founded in 1876 and is based in Antwerp, Belgium.

www.avh.be

24,384

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ACKB.BR

View More

Performance Overview: ACKB.BR

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .

YTD Return

ACKB.BR
20.57%
BEL 20 (^BFX)
5.24%

1-Year Return

ACKB.BR
36.72%
BEL 20 (^BFX)
11.32%

3-Year Return

ACKB.BR
42.79%
BEL 20 (^BFX)
12.09%

5-Year Return

ACKB.BR
119.33%
BEL 20 (^BFX)
51.67%

Compare To: ACKB.BR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACKB.BR

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    7.47B

  • Enterprise Value

    13.48B

  • Trailing P/E

    16.27

  • Forward P/E

    16.08

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.24

  • Price/Book (mrq)

    1.41

  • Enterprise Value/Revenue

    2.23

  • Enterprise Value/EBITDA

    10.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.61%

  • Return on Assets (ttm)

    2.27%

  • Return on Equity (ttm)

    9.14%

  • Revenue (ttm)

    6.04B

  • Net Income Avi to Common (ttm)

    459.87M

  • Diluted EPS (ttm)

    14.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.03B

  • Total Debt/Equity (mrq)

    28.72%

  • Levered Free Cash Flow (ttm)

    231.57M

Research Analysis: ACKB.BR

View More

Company Insights: ACKB.BR

Research Reports: ACKB.BR

View More

People Also Watch